ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Comment le bénéfice par action récent de RSMDF se compare-t-il aux attentes ?
Le bénéfice par action le plus récent de Resmed Inc est de $2.81, battement les attentes de $2.75.
Comment les revenus de Resmed Inc RSMDF se sont-ils comportés au dernier trimestre ?
Les revenus de Resmed Inc pour le dernier trimestre s'élèvent à $2.81
Quelle est l'estimation des revenus pour Resmed Inc ?
Selon 18 analystes de Wall Street, l'estimation des revenus de Resmed Inc varie de $1.51B à $1.36B
Quel est le score de qualité des bénéfices pour Resmed Inc ?
Resmed Inc a un score de qualité des bénéfices de /. Le score est basé sur quatre dimensions : rentabilité, croissance, génération de trésorerie et allocation de capital, et effet de levier.
Quand Resmed Inc publie-t-elle ses résultats ?
Le prochain rapport de résultats de Resmed Inc est attendu pour 2026-04-29
Quels sont les bénéfices attendus de Resmed Inc ?
Les bénéfices attendus de Resmed Inc s'élèvent à $1.41B, selon les analystes de Wall Street.
Resmed Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Les bénéfices récents de Resmed Inc s'élèvent à $1.42B, battement les attentes.